Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0085 (20.48%)
At close: Feb 12, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $4.23 million as of February 13, 2026. Its market cap has decreased by -54.73% in one year.
Market Cap
4.23M
Enterprise Value
7.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 4.23M, a decrease of -96.41%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 5.10M | 24.38% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 5.96M |
| Orgenesis | 5.90M |
| GPL Holdings | 5.83M |
| AXIM Biotechnologies | 5.12M |
| Enzon Pharmaceuticals | 5.01M |
| Bioxytran | 4.93M |
| Burzynski Research Institute | 4.47M |